Pinoxepin
- Level
- Commodity
- Parent
- 51334400
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51334412This classification denotes a dopamine antagonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y3YKO9X8N8. European Medicines Agency schedules Pinoxepin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09856MIG. Pinoxepin generally arises in the molecular formula C23H27CLN2O2. The term PINOXEPIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 22, no. 10, 1968, list 8.) PINOXEPIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule pinoxepin under HS 29349990 and SITC 51579. As of Q4 2014, PINOXEPIN remains the US FDA Preferred Term for this commodity. Pinoxepin bears US NLM identifiers UMLS ID C2827300 and NCI Concept Code C84062. SMILES: CLC1CC2C(=C\CCN3CCN(CC3)CCO)/C3C(COC2CC1)CCCC3.
Same parent
Under 51334400 · 21Activities that produce or sell this
KBLI · 8Inherited from family 51330000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.